BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dow JM, Mauri M, Scott TA, Wren BW. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Review of Vaccines 2020;19:507-27. [DOI: 10.1080/14760584.2020.1775077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Kay EJ, Mauri M, Willcocks SJ, Scott TA, Cuccui J, Wren BW. Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines. Microb Cell Fact 2022;21:66. [PMID: 35449016 DOI: 10.1186/s12934-022-01792-7] [Reference Citation Analysis]
2 Nicolardi S, Danuser R, Dotz V, Domínguez-Vega E, Al Kaabi A, Beurret M, Anish C, Wuhrer M. Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry. Anal Chem 2022. [PMID: 35293727 DOI: 10.1021/acs.analchem.1c04690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Terra VS, Mauri M, Sannasiddappa TH, Smith AA, Stevens MP, Grant AJ, Wren BW, Cuccui J; Glycoengineering of Veterinary Vaccines consortium (GoVV). PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome. Microb Cell Fact 2022;21:6. [PMID: 34986868 DOI: 10.1186/s12934-021-01728-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhu H, Rollier CS, Pollard AJ. Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Rev Vaccines 2021;:1-24. [PMID: 34550840 DOI: 10.1080/14760584.2021.1984889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mauri M, Sannasiddappa TH, Vohra P, Corona-Torres R, Smith AA, Chintoan-Uta C, Bremner A, Terra VS, Abouelhadid S, Stevens MP, Grant AJ, Cuccui J, Wren BW; Glycoengineering of Veterinary Vaccines Consortium. Multivalent poultry vaccine development using Protein Glycan Coupling Technology. Microb Cell Fact 2021;20:193. [PMID: 34600535 DOI: 10.1186/s12934-021-01682-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Samaras JJ, Mauri M, Kay EJ, Wren BW, Micheletti M. Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. Microb Cell Fact 2021;20:104. [PMID: 34030723 DOI: 10.1186/s12934-021-01588-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Knoot CJ, Robinson LS, Harding CM. A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS. Glycobiology 2021:cwab043. [PMID: 33997889 DOI: 10.1093/glycob/cwab043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]